Related Experiment Video
Updated: Mar 24, 2026
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Molecular pathogenesis of human amyloidosis: Lessons from β2 -microglobulin-related amyloidosis
Hironobu Naiki1, Tadakazu Okoshi1, Daisaku Ozawa1
1Department of Pathological Sciences, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Abstract:
Amyloidosis refers to a group of diseases with amyloid fibrils deposited in various organs and is classified into more than 30 diseases in humans based on the kind of amyloid protein. In order to elucidate the molecular pathogenesis of human amyloidosis, we studied the molecular mechanism of amyloid fibril formation in vitro. We first developed a novel fluorometric method to determine amyloid fibrils in vitro based on the unique characteristics of thioflavin T. We next proposed a nucleation-dependent polymerization model to explain the general mechanism of amyloid fibril formation in vitro. Based on this model, we characterized the biological molecular interactions that promote or inhibit amyloid fibril formation in vitro and developed models of pathological molecular environment for inducing human β2-microglobulin-related amyloidosis in long-term hemodialysis patients. We also proposed a novel and attractive cytotoxic mechanism of β2-microglobulin amyloid fibrils, that is, the disruption of endosomal/lysosomal membranes by endocytosed amyloid fibrils. These findings may be useful to elucidate the molecular pathogenesis of other kinds of human amyloidosis.
Insights
Researchers developed a new method to study amyloid fibril formation, revealing a nucleation-dependent polymerization model. This model helps understand amyloidosis, including beta2-microglobulin amyloidosis in dialysis patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Amyloidosis encompasses over 30 human diseases characterized by amyloid fibril deposition in organs.
- Understanding the molecular pathogenesis of amyloidosis is crucial for developing effective treatments.
Purpose of the Study:
- To elucidate the molecular pathogenesis of human amyloidosis.
- To investigate the in vitro formation of amyloid fibrils.
- To develop models for beta2-microglobulin amyloidosis.
Main Methods:
- Developed a novel fluorometric method using thioflavin T to quantify amyloid fibrils in vitro.
- Proposed and validated a nucleation-dependent polymerization model for amyloid fibril formation.
- Characterized molecular interactions influencing fibril formation and created models for beta2-microglobulin amyloidosis.
Main Results:
- Established a nucleation-dependent polymerization model for amyloid fibril formation.
- Identified factors promoting and inhibiting fibril formation in vitro.
- Developed a pathological model for beta2-microglobulin amyloidosis relevant to hemodialysis patients.
- Proposed a cytotoxic mechanism involving endosomal/lysosomal membrane disruption by amyloid fibrils.
Conclusions:
- The nucleation-dependent polymerization model provides a framework for understanding amyloid fibril formation.
- Findings offer insights into the pathogenesis of beta2-microglobulin amyloidosis and potentially other amyloidosis types.
- The proposed cytotoxic mechanism highlights a novel pathway for amyloid-induced cellular damage.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
03:03Amyloid Fibrils